TAMPA, Fla., Feb. 20, 2013 /PRNewswire-iReach/ -- Florida Peptides is a United States based provider of peptides for research purposes. Peptides are short polymers of amino acid monomers linked together by peptide bonds.
Research peptides are used around the world for a number of reason but most notably to test the effects of growth hormone related hormones and growth hormone related peptides and their effects.
Research peptides act in a similar manner as prohormones, which when taken convert to a hormone. The main differences are that prohormones are often associated with testosterone boosters and peptides are usually associated with growth hormone releasing product.
Another difference is that in some cases prohormones actually convert to testosterone and research peptides typically just increase the release of growth hormone. This is not always the case as certain prohormones are known as testosterone boosters and act in a similar manner to research peptides, meaning they too can increase natural production of growth hormone over a given period of time. It has been shown that an increased amount of testosterone can lead to increased HGH as well as IGF-1 levels in the human body.
Florida Peptides carries a variety of products such as: CJC-1295, GHRP-6, Sermorelin, GHRP-2, CJC-1295 DAC, Bacteriostatic 0.9% Sodium Chloride and hard to find Bacteriostatic Water.
The site also has a dedicated blog page used to inform and educate potential buyers of some prior research conducted regarding these peptide products.
Florida Peptides is proud to offer high quality research grade peptides like CJC-1295 for research purposes.
FloridaPeptides.com is a United States based distributor of the highest grade research peptides and Amino Acid Derivatives available. We utilize the most advanced techniques to ensure fast and secure product delivery. These items are intended for research purposes only.
To place an order or learn more please visit the following link- http://floridapeptides.com/
|SOURCE US Peptides LLC|
Copyright©2012 PR Newswire.
All rights reserved